Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis-Reference-Cited by-同舟云学术

Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis

Published:2023-09 Issue: Volume:549 Page:117554
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Rigo-Bonnin Raúl^ORCID,Rosselló-Palmer Elena,Sánchez-García Arnau,Pallarés-Borràs Mireia,Martínez Yurema,Videla Sebastián,Otero Aurema,Lloberas Núria,Hueso Miguel

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference32 articles.

1. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups;Lip;Int. J. Cardiol.,2016

2. New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness;Mani;Drug Des. Devel. Ther.,2014

3. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications;Fenger-Eriksen;Acta Anaesthesiol. Scand.,2014

4. Apixaban dosing patterns versus warfarin in patients with nonvalvular atrial fibrillation receiving dialysis: A retrospective cohort study;Wetmore;Am. J. Kidney Dis.,2022

5. Risk of stroke, bleeding, and death in patients with nonvalvular atrial fibrillation and chronic kidney disease;Arnson;Cardiology,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Apixaban Pharmacokinetics, Pharmacodynamics, and Safety in Hemodiafiltration Patients;Kidney International Reports;2024-09

2. Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography‐tandem mass spectrometry method;Journal of Mass Spectrometry;2024-08-26